Volume 72, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


While resistance to older antimalarials is increasingly common, newer antimalarials are still not widely available or affordable in much of Africa. Older antimalarials used in combination might be adequately effective in treating uncomplicated malaria. The objective of this study was to determine whether the combination of sulfadoxine-pyrimethamine (SP) and chloroquine (CQ) is superior to SP alone in the treatment of uncomplicated malaria in Nigerian patients. We recruited subjects with malaria, defined as the presence of fever and parasitemia > 2,000/μL, from the outpatient department of a Nigerian teaching hospital. We alternately assigned 280 subjects to receive SP with or without CQ. We assessed clinical and parasitologic responses on days 1, 2, 3, 7, and 14. A total of 114 in the SP + CQ group and 116 in the SP group completed the study. By day 3, 97 (75%) in the SP + CQ group and 52 (42%) in the SP group had cleared their parasitemia ( < 0.001); by day 14, 112 (98%) and 67 (58%), respectively, had cleared their parasitemia ( < 0.001). By day 3, 82 (63%) in the SP + CQ group and 20 (16%) in the SP group were symptom free ( < 0.001). When a modified World Health Organization clinical classification system was used, adequate clinical response occurred in 99 (87%) and 61 (53%) of those in the SP + CQ and SP groups, respectively. RI, RII, and RIII resistance to SP + CQ was 7.9%, 3.5%, and 1.8%, respectively, whereas resistance to SP was 23%, 17%, and 5%, respectively. Combined SP + CQ is superior to SP alone for treatment of uncomplicated malaria in Nigerian patients and may prolong the usefulness of these readily available and affordable drugs.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization/UNICEF, 2003. Africa Malaria Report 2003. Geneva: World Health Organization. WHO/CDS/MAL/2003: 1093.
  2. Remme JHF, Binka F, Nabarro D, 2001. Toward a framework and indicators for monitoring Roll Back Malaria. Am J Trop Med Hyg 64 (Suppl): 76–84. [Google Scholar]
  3. Premji Z, Makwaya C, Minjas JN, 1999. Current clinical efficacy of chloroquine for the treatment of Plasmodium falciparum infections in urban Dar es Salaam, United Republic of Tanzania. Bull World Health Organ 77 : 740–744. [Google Scholar]
  4. Ronn AM, Msageni HA, Mhina J, Wernsdorfe WH, Bygbjerg IC, 1996. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg 90 : 179–181. [Google Scholar]
  5. Zucker JR, Ruebush TK II, Obonyo C, Otieno J, Campell CC, 2003. The mortality consequensces of the continued use of chloroquine in Africa: Experience in Siaya, Western Kenya. Am J Trop Med Hyg 68 : 386–390. [Google Scholar]
  6. Nsimba B, Malonga DA, Mouata AM, Louya F, Kiori J, Malanda M, Yocka D, Oko-Ossho J, Ebata-Mongo S, Le Bras J, 2004. Efficacy of sulfadoxine/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo. Am J Trop Med Hyg 70 : 133–138. [Google Scholar]
  7. Bijl HM, Kager J, Koetsier DW, van der Werf TS, 2000. Chloroquine- and sulfadoxine-pyrimethamine- resistant falciparum malaria in vivo - a pilot study in rural Zambia. Trop Med Int Health 5 : 692–695. [Google Scholar]
  8. McIntosh HM, 2001. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria. Cochrane Database Syst Rev 2001: CD000386.
  9. World Health Organization, 1996. Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Malaria in Areas with Intense Transmission. Geneva: World Health Organization. WHO/MAL/96: 1077.
  10. Doctors Without Borders/Médecins Sans Frontières (MSF), 2002. International Activity Report: Nigeria. www.doctorswithoutborders.org/publications/ar/i2002/Nigeria.shtml (accessed March 18, 2004).
  11. Henry MC, Eggelte TA, Watson P, Docters van Leeuwen B, Bakker DA, Kluin J, 1996. Response of childhood malaria to chloroquine and Fansidar in an area of intermediate chloroquine resistance in Côte d’Ivoire. Trop Med Int Health 1 : 610–615. [Google Scholar]
  12. Gorissen E, Ashruf G, Lamboo M, Bennebroek J, Gikunda S, Mbaruku G, Kager PA, 2000. In vivo efficacy study of amodiaquine and sulfadoxine/pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania. Trop Med Int Health 5 : 459–463. [Google Scholar]
  13. Plowe CV, Kublin JG, Dzinjalamala FK, Kamwendo DS, Mukadam RA, Chimpeni P, Molyneux ME, Taylor TE, 2004. Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study. BMJ 328 : 545. [Google Scholar]
  14. Hugosson E, Tarimo D, Troye-Blomberg M, Montgomery SM, Premji Z, Björkman A, 2003. Antipyretic, parasitologic, and immunologic effects of combining sulfadoxine/pyrimethamine with chloroquine or paracetamol for treating uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg 69 : 366–371. [Google Scholar]
  15. Bojang KA, Schneider G, Forck S, Obaro SK, Jaffar S, Pinder M, Rowley J, Greenwood BM, 1998. A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children. Trans R Soc Trop Med Hyg 92 : 73–76. [Google Scholar]
  16. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK II, Danis M, Greenwood BM, Anderson RM, Olliaro P, 1999. Averting a malaria disaster. Lancet 353 : 1965–1967. [Google Scholar]
  17. Bustos DG, Canfield CJ, Canete-Miguel E, Hutchinson DB, 1999. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute plasmodium falciparum malaria in the Philippines. J Infect Dis 179 : 1587–1590. [Google Scholar]
  18. Sowunmi A, Fehintola FA, Adedeji AA, Falade AG, Falade CO, Akinyinka OO, Oduola AM, 2000. Comparative efficacy of chloroquine plus chlorpheniramine alone and in a sequential combination with sulfadoxine-pyrimethamine, for the treatment of acute, uncomplicated, falciparum malaria in children. Ann Trop Med Parasitol 94 : 209–217. [Google Scholar]
  19. Gasasira AF, Dorsey G, Nzarubara B, Staedke SG, Nassali A, Rosenthal PJ, Kamya MR, 2003. Comparative efficacy of amodiaquine-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Am J Trop Med Hyg 68 : 127–132. [Google Scholar]
  20. Attaran A, Barnes KI, Curtis C, d’Alessandro U, Fanello CI, Galinski MR, Kokwaro G, Looareesuwan S, Makanga M, Mutabingwa TK, Talisuna A, Trape JF, Watkins WM, 2004. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 363 : 237–240. [Google Scholar]
  21. Bloland PB, 2003. A contrarian view of malaria therapy policy in Africa. Am J Trop Med Hyg 68 : 125–126. [Google Scholar]
  22. Sutherland CJ, Alloueche A, Curtis J, Drakeley CJ, Ord R, Duraisingh M, Greenwood BM, Pinder M, Warhurst D, Targett GA, 2002. Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. Am J Trop Med Hyg 67 : 578–585. [Google Scholar]
  23. Sowunmi A, Fateye BA, 2003. Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. Trop Med Int Health 8 : 783–792. [Google Scholar]
  24. Bloland PB, Etling M, Meek S, 2000. Combination therapy for malaria in Africa: Hype or hope? Bull World Health Organ 78 : 1378–1385. [Google Scholar]
  25. Alifrangis M, Lemnge MM, Ronn AM, Segeja MD, Magesa SM, Khalil IF, Bygbjerg IC, 2003. Increasing prevalence of wild-types in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets. Am J Top Med Hyg 69 : 238–243. [Google Scholar]
  26. Zimmerman PA, 2003. Roll back of Plasmodium falciparum antifolate resistance by insecticide-treated nets. Am J Trop Med Hyg 69 : 236–237. [Google Scholar]

Data & Media loading...

  • Received : 24 Apr 2004
  • Accepted : 27 Sep 2004

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error